Cardiology

Rare Diseases

Effectively addressing rare diseases is one of the greatest challenges

for researchers, healthcare professionals, and patients living with these often unpredictable conditions.

Pulmonary Arterial Hypertension Wilson’s Disease Hyperammonemia due to Organic Acidemias

Hematology / Oncology

This is a rapidly evolving field in terms of research and development.

Our core commitment is to meet the needs of cancer patients by providing innovative and effective treatments, aiming to improve their quality of life throughout their journey with the disease.

Multiple Myeloma Prostate Cancer Renal Cell Carcinoma Chronic Myeloid Leukemia Hematopoietic Stem Cell Transplantation

Infections

Antiviral medicines constitute an important part of the company’s portfolio.

It is a type of pharmaceutical treatment that reduces both the intensity and duration of viral infection symptoms.

Engaging in such a therapeutic field, which focuses on reducing the likelihood of infections and treating their symptoms, particularly in patients with AIDS or herpes simplex virus (HSV) — further strengthens our commitment to providing reliable treatment solutions that effectively serve the public health.

HIV & AIDS

We focus on patient care in cardiovascular diseases, with an emphasis on rare conditions

such as pulmonary arterial hypertension, as well as conditions without available treatment such as orthostatic hypotension.

Orthostatic Hypotension

Dermatology / Rheumatology

The management of dermatological and rheumatological diseases remains an ongoing challenge, as these are often chronic and inflammatory conditions that significantly impact patients’ quality of life.

The continuous progress in research and the development of targeted therapies play a key role in improving disease management and enhancing the quality of life of people living with these conditions.